United States · FDA National Drug Code directory
OPZELURA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50881-007_af30042b-ecb2-4e8b-82be-117685dff4ed
- Product NDC
- 50881-007
- Form
- CREAM
- Composition / generic term
- ruxolitinib
- Labeler
- Incyte Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210921
- Source listing expiry
- 20271231
Source-listed ingredients
- RUXOLITINIB PHOSPHATE — 15 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (50881-007-04) / 5 g in 1 TUBE · 50881-007-04
- 1 TUBE in 1 CARTON (50881-007-05) / 60 g in 1 TUBE · 50881-007-05
- 1 TUBE in 1 CARTON (50881-007-07) / 100 g in 1 TUBE · 50881-007-07
- 1 TUBE in 1 CARTON (50881-007-14) / 3 g in 1 TUBE · 50881-007-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →